Publicaciones en colaboración con investigadores/as de Indiana University – Purdue University Indianapolis (1)

2020

  1. Phase 1 study of mTORC1/2 inhibitor sapanisertib (TAK-228) in advanced solid tumours, with an expansion phase in renal, endometrial or bladder cancer

    British Journal of Cancer, Vol. 123, Núm. 11, pp. 1590-1598